当前位置:首页 - 行情中心 - 博济医药(300404) - 财务分析 - 现金流量表

博济医药

(300404)

  

流通市值:30.74亿  总市值:41.56亿
流通股本:2.85亿   总股本:3.86亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金187,529,744.21865,099,427.17578,586,582.28384,396,444.29
  收到其他与经营活动有关的现金8,959,576.3965,172,592.8137,794,982.8723,992,185.29
  经营活动现金流入小计196,489,320.6930,272,019.98616,381,565.15408,388,629.58
  购买商品、接受劳务支付的现金96,282,682.37401,718,137.35290,206,511.22183,515,192.38
  支付给职工以及为职工支付的现金90,739,664.36349,143,166.48254,184,463.89161,596,469.81
  支付的各项税费11,756,426.9148,133,702.828,928,772.4918,023,165.11
  支付其他与经营活动有关的现金8,839,957.8644,268,696.8135,266,842.6524,008,534.85
  经营活动现金流出小计207,618,731.5843,263,703.44608,586,590.25387,143,362.15
  经营活动产生的现金流量净额-11,129,410.987,008,316.547,794,974.921,245,267.43
二、投资活动产生的现金流量:
  收回投资收到的现金1,382,041.699,174,117.815,499,117.814,749,117.81
  取得投资收益收到的现金873,928.62,207,761.881,075,198.42839,399.97
  处置固定资产、无形资产和其他长期资产收回的现金净额8,663.712,7502,7502,750
  收到的其他与投资活动有关的现金96,000,000472,100,000349,700,000272,000,000
  投资活动现金流入小计98,264,634483,484,629.69356,277,066.23277,591,267.78
  购建固定资产、无形资产和其他长期资产支付的现金3,078,088.4318,706,735.3614,842,659.399,495,812.36
  投资支付的现金-7,580,4301,280,4301,280,430
  支付其他与投资活动有关的现金270,500,000503,600,000491,600,000404,100,000
  投资活动现金流出小计273,578,088.43529,887,165.36507,723,089.39414,876,242.36
  投资活动产生的现金流量净额-175,313,454.43-46,402,535.67-151,446,023.16-137,284,974.58
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,090,238.2826,430,489.2925,588,613.1114,044,736.46
  其中:子公司吸收少数股东投资收到的现金-125,000--
  取得借款收到的现金56,275.944,689,70043,189,70043,189,700
  收到其他与筹资活动有关的现金25,799,247.23191,668.55170,559.96126,445.38
  筹资活动现金流入小计26,945,761.4171,311,857.8468,948,873.0757,360,881.84
  偿还债务支付的现金1,800,00045,505,520.8542,549,914.1641,954,914.16
  分配股利、利润或偿付利息支付的现金286,809.786,122,976.355,332,110.89720,315.45
  其中:子公司支付给少数股东的股利、利润-200,000--
  支付其他与筹资活动有关的现金443,733.82,754,772.032,473,663.941,971,441.12
  筹资活动现金流出小计2,530,543.5854,383,269.2350,355,688.9944,646,670.73
  筹资活动产生的现金流量净额24,415,217.8316,928,588.6118,593,184.0812,714,211.11
四、汇率变动对现金及现金等价物的影响-490,207.28-662,292.83-333,707.79-119,795.01
五、现金及现金等价物净增加额-162,517,854.7856,872,076.65-125,391,571.97-103,445,291.05
  加:期初现金及现金等价物余额325,430,707.48268,558,630.83268,558,630.83268,558,630.83
  期末现金及现金等价物余额162,912,852.7325,430,707.48143,167,058.86165,113,339.78
补充资料:
  净利润-32,909,794.36-17,560,429.1
  资产减值准备-30,107,922.37-13,366,516.57
  固定资产和投资性房地产折旧-24,889,531.26-12,437,222.4
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-24,889,531.26-12,437,222.4
  无形资产摊销-1,266,085.94-567,819.13
  长期待摊费用摊销-7,241,563.89-6,073,762.7
  固定资产报废损失-5,367.44-4,491.93
  公允价值变动损失--1,482,850.18--914,273.99
  财务费用-1,609,163.99-901,318.79
  投资损失--837,663.49--301,173.62
  递延所得税--12,156,938.67--4,488,306.8
  其中:递延所得税资产减少--11,874,430.91--4,677,422.95
    递延所得税负债增加--282,507.76-189,116.15
  存货的减少--41,936,456.21--56,271,127.01
  经营性应收项目的减少--80,699,046.9--47,644,764.79
  经营性应付项目的增加-124,107,818.76-78,962,251.88
  不涉及现金收支的投资和筹资活动金额其他项目-526,664.74-526,664.74
  现金的期末余额-325,430,707.48-165,113,339.78
  减:现金的期初余额-268,558,630.83-268,558,630.83
  现金及现金等价物的净增加额-56,872,076.65--103,445,291.05
公告日期2026-04-252026-04-252025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑